bryonolic acid
structure given in first source; an anti-allergy agent isolated from Luffa cylindrica, the roots of Bryonia dioica, and the fruit hulls of Sandrica indicum
Also Known As:
3beta-hydroxy-D-C-friedoolean-8-en-29-oic acid
Networked: 5
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Khallouki, Farid:
1 article
(02/2018)
|
2. | Owen, Robert Wyn:
1 article
(02/2018)
|
3. | Poirot, Marc:
1 article
(02/2018)
|
4. | Silvente-Poirot, Sandrine:
1 article
(02/2018)
|
5. | Frahm, August Wilhelm:
1 article
(06/2009)
|
6. | Jiratchariyakul, Weena:
1 article
(06/2009)
|
7. | Kongtun, Sumonthip:
1 article
(06/2009)
|
8. | Kummalue, Tanawan:
1 article
(06/2009)
|
9. | Kunnachak, Somyos:
1 article
(06/2009)
|
10. | Tan-ariya, Peerapan:
1 article
(06/2009)
|
Related Diseases
1. | Neoplasms (Cancer)
|
2. | Melanoma (Melanoma, Malignant)
|
3. | Lung Neoplasms (Lung Cancer)
06/01/2009
- " The root extract had higher IC (50) values than bryonolic acid (1) against three breast cancer cell lines (MCF7 = 267/121, T47D = 316/124, MDA-MB435 = 140/90 microL/mL) and one lung cancer cell line (A549 = 106/100 microL/mL). " 06/01/2009
- " and bryonolic acid (1), its main constituent, as well as the fruit juice and cucurbitacin B (3), its main constituent, were tested for cytotoxicity against four human breast cancer cell lines (SKBR3, MCF7, T47D, and MDA-MB435), two lung cancer cell lines (A549 and SK-LU1), and one colon cancer cell line (Caco-2). "
|
4. | Hypersensitivity (Allergy)
|
5. | Colonic Neoplasms (Colon Cancer)
|
|
Related Drugs and Biologics